ImmuCell Corporation Interest Expense, Other
ImmuCell Corporation (ICCC) reported Interest Expense, Other of $314.36 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Expense Statement
us-gaap:InterestExpenseOther · last filed 2022-03-30
- ImmuCell Corporation interest expense, other for the quarter ending 2021-12-31 was $76.78K, a 1.31% decline year-over-year.
- ImmuCell Corporation interest expense, other for the quarter ending 2021-09-30 was $78.53K, a 3.40% increase year-over-year.
- ImmuCell Corporation interest expense, other for the quarter ending 2021-06-30 was $79.42K, a 3.07% increase year-over-year.
- ImmuCell Corporation interest expense, other for the quarter ending 2021-03-31 was $79.64K, a 56.22% decline year-over-year.
- ImmuCell Corporation interest expense, other for fiscal 2021 was $314.36K, a 23.83% decline from fiscal 2020.
- ImmuCell Corporation interest expense, other for fiscal 2020 was $412.69K, a 4.42% decline from fiscal 2019.
- ImmuCell Corporation interest expense, other for fiscal 2019 was $431.79K, a 0.94% increase from fiscal 2018.
- ImmuCell Corporation interest expense, other for fiscal 2018 was $427.78K, a 95.72% increase from fiscal 2017.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 3 month as first filed | Interest Expense, Other 6 month | Interest Expense, Other 6 month as first filed | Interest Expense, Other 9 month | Interest Expense, Other 9 month as first filed | Interest Expense, Other 12 month | Interest Expense, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $76.78K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $155.31K derived: sum of 2 quarters · filed 2022-03-30 | $234.72K derived: sum of 3 quarters · filed 2022-03-30 | $314.36K 10-K · filed 2022-03-30 | ||||
| 2021-09-30 | $78.53K 10-Q · filed 2021-11-15 | $157.94K derived: sum of 2 quarters · filed 2021-11-15 | $237.58K 10-Q · filed 2021-11-15 | $315.38K derived: sum of 4 quarters · filed 2022-03-30 | ||||
| 2021-06-30 | $79.42K 10-Q · filed 2021-08-12 | $159.05K 10-Q · filed 2021-08-12 | $236.85K derived: sum of 3 quarters · filed 2022-03-30 | $312.79K derived: sum of 4 quarters · filed 2022-03-30 | ||||
| 2021-03-31 | $79.64K 10-Q · filed 2021-05-13 | $157.43K derived: sum of 2 quarters · filed 2022-03-30 | $233.37K derived: sum of 3 quarters · filed 2022-03-30 | $310.42K derived: sum of 4 quarters · filed 2022-03-30 | ||||
| 2020-12-31 | $77.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $153.74K derived: sum of 2 quarters · filed 2022-03-30 | $230.79K derived: sum of 3 quarters · filed 2022-03-30 | $412.69K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $75.94K 10-Q · filed 2021-11-15 | $152.99K derived: sum of 2 quarters · filed 2021-11-15 | $334.89K 10-Q · filed 2021-11-15 | $499.94K 10-Q · filed 2020-11-12 | $433.65K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $77.05K 10-Q · filed 2021-08-12 | $258.95K 10-Q · filed 2021-08-12 | $424.00K 10-Q · filed 2020-08-12 | $357.71K derived: sum of 3 quarters · filed 2021-08-12 | $464.71K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $181.90K 10-Q · filed 2021-05-13 | $346.95K 10-Q · filed 2020-05-13 | $280.66K derived: sum of 2 quarters · filed 2021-05-13 | $387.66K derived: sum of 3 quarters · filed 2021-05-13 | $499.65K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $98.76K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $205.76K derived: sum of 2 quarters · filed 2021-03-30 | $317.75K derived: sum of 3 quarters · filed 2021-03-30 | $431.79K 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | $107.00K 10-Q · filed 2020-11-12 | $218.99K derived: sum of 2 quarters · filed 2020-11-12 | $333.03K 10-Q · filed 2020-11-12 | $448.88K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $111.99K 10-Q · filed 2020-08-12 | $226.03K 10-Q · filed 2020-08-12 | $341.88K derived: sum of 3 quarters · filed 2020-08-12 | $451.53K derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $114.04K 10-Q · filed 2020-05-13 | $229.89K derived: sum of 2 quarters · filed 2020-05-13 | $339.54K derived: sum of 3 quarters · filed 2020-05-13 | $445.81K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $115.85K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $225.50K derived: sum of 2 quarters · filed 2020-03-27 | $331.77K derived: sum of 3 quarters · filed 2020-03-27 | $427.78K 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | $109.65K 10-Q · filed 2019-11-12 | $215.92K derived: sum of 2 quarters · filed 2019-11-12 | $311.93K 10-Q · filed 2019-11-12 | $393.94K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $106.27K 10-Q · filed 2019-08-12 | $202.28K 10-Q · filed 2019-08-12 | $284.29K derived: sum of 3 quarters · filed 2019-08-12 | $337.46K derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $96.02K 10-Q · filed 2019-05-13 | $178.02K derived: sum of 2 quarters · filed 2019-05-13 | $231.19K derived: sum of 3 quarters · filed 2019-05-13 | $274.68K derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $82.01K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $135.18K derived: sum of 2 quarters · filed 2019-03-22 | $178.67K derived: sum of 3 quarters · filed 2019-03-22 | $218.57K 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $53.17K 10-Q · filed 2018-11-13 | $96.66K derived: sum of 2 quarters · filed 2018-11-13 | $136.56K 10-Q · filed 2018-11-13 | $174.97K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $43.49K 10-Q · filed 2018-08-13 | $83.39K 10-Q · filed 2018-08-13 | $121.80K derived: sum of 3 quarters · filed 2018-08-13 | $163.25K derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $39.90K 10-Q · filed 2018-05-14 | $78.31K derived: sum of 2 quarters · filed 2018-05-14 | $119.76K derived: sum of 3 quarters · filed 2018-05-14 | $164.69K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $38.41K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $79.86K derived: sum of 2 quarters · filed 2018-03-29 | $124.79K derived: sum of 3 quarters · filed 2018-03-29 | $161.70K 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | $41.45K 10-Q · filed 2017-11-13 | $38.93K 10-Q · filed 2016-11-10 | $86.39K derived: sum of 2 quarters · filed 2017-11-13 | $123.29K 10-Q · filed 2017-11-13 | $116.92K 10-Q · filed 2016-11-10 | $165.83K derived: sum of 4 quarters · filed 2017-11-13 | ||
| 2016-06-30 | $44.94K 10-Q · filed 2017-08-14 | $42.40K 10-Q · filed 2016-08-11 | $81.84K 10-Q · filed 2017-08-14 | $78.00K 10-Q · filed 2016-08-11 | $124.38K derived: sum of 3 quarters · filed 2017-08-14 | $139.47K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $36.91K 10-Q · filed 2017-05-11 | $35.60K 10-Q · filed 2016-05-11 | $79.45K derived: sum of 2 quarters · filed 2017-05-11 | $94.53K derived: sum of 3 quarters · filed 2017-05-11 | $107.41K derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | $42.54K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $57.62K derived: sum of 2 quarters · filed 2017-03-30 | $70.51K derived: sum of 3 quarters · filed 2017-03-30 | $83.58K 10-K · filed 2017-03-30 | $80.23K 10-K · filed 2016-03-25 | |||
| 2015-09-30 | $15.08K 10-Q · filed 2016-11-10 | -$15.08K 10-Q · filed 2015-11-12 | $27.97K derived: sum of 2 quarters · filed 2016-11-10 | $41.04K 10-Q · filed 2016-11-10 | -$41.04K 10-Q · filed 2015-11-12 | $143.01K derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | $12.88K 10-Q · filed 2016-08-11 | -$12.88K 10-Q · filed 2015-08-13 | $25.95K 10-Q · filed 2016-08-11 | -$25.95K 10-Q · filed 2015-08-13 | $127.93K derived: sum of 3 quarters · filed 2016-08-11 | $113.42K derived: sum of 4 quarters · filed 2016-08-11 | ||
| 2015-03-31 | $13.07K 10-Q · filed 2016-05-11 | -$13.07K 10-Q · filed 2015-05-12 | $115.05K derived: sum of 2 quarters · filed 2016-05-11 | $100.53K derived: sum of 3 quarters · filed 2016-05-11 | $85.86K derived: sum of 4 quarters · filed 2016-05-11 | |||
| 2014-12-31 | $101.97K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $87.46K derived: sum of 2 quarters · filed 2016-03-25 | $72.79K derived: sum of 3 quarters · filed 2016-03-25 | $57.83K 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | -$14.51K 10-Q · filed 2015-11-12 | $14.51K 10-Q · filed 2014-11-12 | -$29.18K derived: sum of 2 quarters · filed 2015-11-12 | -$44.15K 10-Q · filed 2015-11-12 | $44.15K 10-Q · filed 2014-11-12 | -$28.08K derived: sum of 4 quarters · filed 2016-03-25 | ||
| 2014-06-30 | -$14.67K 10-Q · filed 2015-08-13 | $14.67K 10-Q · filed 2014-08-13 | -$29.63K 10-Q · filed 2015-08-13 | $29.63K 10-Q · filed 2014-08-13 | -$13.57K derived: sum of 3 quarters · filed 2016-03-25 | $2.96K derived: sum of 4 quarters · filed 2016-03-25 | ||
| 2014-03-31 | -$14.96K 10-Q · filed 2015-05-12 | $14.96K 10-Q · filed 2014-05-14 | $1.10K derived: sum of 2 quarters · filed 2016-03-25 | $17.63K derived: sum of 3 quarters · filed 2016-03-25 | $34.51K derived: sum of 4 quarters · filed 2016-03-25 | |||
| 2013-12-31 | $16.07K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $32.59K derived: sum of 2 quarters · filed 2016-03-25 | $49.47K derived: sum of 3 quarters · filed 2016-03-25 | $66.69K 10-K · filed 2016-03-25 | ||||
| 2013-09-30 | $16.52K 10-Q · filed 2014-11-12 | $33.40K derived: sum of 2 quarters · filed 2014-11-12 | $50.62K 10-Q · filed 2014-11-12 | $68.76K derived: sum of 4 quarters · filed 2015-03-26 | ||||
| 2013-06-30 | $16.88K 10-Q · filed 2014-08-13 | $34.10K 10-Q · filed 2014-08-13 | $52.24K derived: sum of 3 quarters · filed 2015-03-26 | $70.91K derived: sum of 4 quarters · filed 2015-03-26 | ||||
| 2013-03-31 | $17.22K 10-Q · filed 2014-05-14 | $35.36K derived: sum of 2 quarters · filed 2015-03-26 | $54.03K derived: sum of 3 quarters · filed 2015-03-26 | $73.01K derived: sum of 4 quarters · filed 2015-03-26 | ||||
| 2012-12-31 | $18.14K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $36.81K derived: sum of 2 quarters · filed 2015-03-26 | $55.79K derived: sum of 3 quarters · filed 2015-03-26 | $75.27K 10-K · filed 2015-03-26 | -$75.27K 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $18.67K 10-Q · filed 2013-11-13 | -$18.67K 10-Q · filed 2012-11-13 | $37.65K derived: sum of 2 quarters · filed 2013-11-13 | $57.13K 10-Q · filed 2013-11-13 | -$57.13K 10-Q · filed 2012-11-13 | $199.72K derived: sum of 4 quarters · filed 2014-03-26 | ||
| 2012-06-30 | $18.98K 10-Q · filed 2013-08-13 | $19.00K 10-Q/A · filed 2012-09-07 | $38.47K 10-Q · filed 2013-08-13 | $38.00K 10-Q/A · filed 2012-09-07 | $181.05K derived: sum of 3 quarters · filed 2014-03-26 | $160.56K derived: sum of 4 quarters · filed 2014-03-26 | ||
| 2012-03-31 | $19.49K 10-Q · filed 2013-05-14 | $162.07K derived: sum of 2 quarters · filed 2014-03-26 | $141.58K derived: sum of 3 quarters · filed 2014-03-26 | $162.58K derived: sum of 4 quarters · filed 2014-03-26 | ||||
| 2011-12-31 | $142.58K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $122.09K derived: sum of 2 quarters · filed 2014-03-26 | $143.09K derived: sum of 3 quarters · filed 2014-03-26 | $81.40K 10-K · filed 2014-03-26 | -$81.40K 10-K · filed 2013-03-28 | |||
| 2011-09-30 | -$20.49K 10-Q · filed 2012-11-13 | $511.00 derived: sum of 2 quarters · filed 2012-11-13 | -$61.19K 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | $21.00K 10-Q/A · filed 2012-09-07 | $40.00K 10-Q/A · filed 2012-09-07 | ||||||
| 2010-12-31 | -$21.61K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |